Spire Healthcare Group stock
Price history
+12.90% over the period1 year: from 221.00 GBp (November 20, 2025) to 249.50 GBp (November 20, 2026), +12.90%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | 249.50 GBp |
| October 30, 2026 | 249.00 GBp |
| September 30, 2026 | 246.50 GBp |
| August 28, 2026 | 235.00 GBp |
| July 31, 2026 | 233.50 GBp |
| June 30, 2026 | 215.00 GBp |
| May 29, 2026 | 221.00 GBp |
| April 30, 2026 | 163.00 GBp |
| March 31, 2026 | 146.00 GBp |
| February 27, 2026 | 203.00 GBp |
| January 30, 2026 | 204.00 GBp |
| December 31, 2025 | 167.00 GBp |
| November 28, 2025 | 229.50 GBp |
| November 20, 2025 | 221.00 GBp |
At a glance
The company
Owns and operates private hospitals and clinics in the UK, providing diagnostics, inpatient and outpatient care across multiple specialties
Latest results
Quarter to June 30, 2026 · EPS -£0.01
TickerLandia's take on Spire Healthcare Group
- Pricier than usual relative to earnings: P/E on the latest fiscal year 62 vs a median of 42 over its last 7 fiscal years.
- Strong point: Market momentum (76/100 in its group). Weak point: Financial strength (8/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
0.00% from the 52-week high
Analysts · 4 analysts
Average target258.00 GBp+3.41% vs. price
Buy 1 · Hold 3 · Sell 0 · Buy
TickerLandia Fingerprint: Spire Healthcare Group
Compared with similar companies: very low financial strength and very low growth.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricelow31
How much it costs relative to what it produces.
Metric Value Position in group Price/book 1.37 15 Price/sales 0.63 13 Forward P/E 14.4 47 EV/EBITDA 11.8 50 Profitabilitylow22
How much it earns on revenue and capital.
Metric Value Position in group ROA 3.2% 8 ROE −0.2% 3 Operating margin 7.6% 13 Gross margin 45.2% 82 Net margin −0.1% 3 Earnings stabilityaverage50
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.9% 92 Loss-making yearscounts in reverse: lower means more earnings stability 1 of 5 annual reports 8 Growthvery low18
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) −283.90% 3 Average revenue growth (3 years) +9.64% 45 Revenue growth (year over year) −0.50% 8 Financial strengthvery low8
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 5.95 3 Interest coverage 1.41 3 Current ratio 0.60 3 Debt/equitycounts in reverse: lower means more financial strength 1.80 25 Dividendaverage42
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 4 years 19 Dividend yield 0.8% 44 Payout ratio 57.5% 62 Market momentumstrong76
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +9.83% 76 Relative strength (6 months) +13.83% 79 1-year return +12.90% 57 Distance from 200-day average +16.69% 90 Risklow39
How much the price swings.
Metric Value Position in group Beta (1 year) 0.56 33 Volatility (60 days) 8.5% 2 Maximum drawdown (12 months) 37.8% 82
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Spire Healthcare Group is pricier than in the past and in line with similar companies
On the latest fiscal year's earnings (2025), Spire Healthcare Group's P/E today is 62.4, above the median of its last 7 fiscal years (41.8; between 25.4 and 108.6 from 2016 to 2025). Spire Healthcare Group's Forward P/E: 14.4, in line with the median of a group of 10 similar companies (13.8).
Compared with 10 similar companies
| Metric | Spire Healthcare Group | Position in the group | Band |
|---|---|---|---|
| Forward P/E | 14.4 | Middle | |
| Operating margin | 7.6% | Low | |
| ROE | -0.2% | Low | |
| Debt/equity | 1.80 | Middle | |
| Price/book | 1.37 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Spire Healthcare Group. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
£792.7M
Latest quarter · Q2 2026
Net income
-£11.8M
Latest quarter · Q2 2026
Quarterly net margin
-1.5%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- £991.48M
- EPS
- 0.00 GBp
- Volume
- 436.34K
- Daily trading
- €2.99M
- Dividend yield
- 0.60%
- Last ex-dividend on May 21, 2026
How Spire Healthcare Group is changing
All resultsRevenue grew 11.4% a year on average over the last 5 years
Revenue has grown for 5 fiscal years in a row
Profitable in 4 of 5 fiscal years
Returns
Spire Healthcare Group returns with dividends
£1,000 invested in Spire Healthcare Group 5 years ago, on November 22, 2021, would be worth £1,053 today with dividends reinvested: +5.25% in total, +1.03% per year. On price alone it would be £1,023 (+2.25%).
| Period | Spire Healthcare Group | FTSE 100 | £1,000 becomes |
|---|---|---|---|
| 1 month | +0.81% | −3.60% | £1,008 |
| 6 months | +12.90% | −0.82% | £1,129 |
| Year to date | +49.40% | +4.18% | £1,494 |
| 1 year | +13.66% | +8.59% | £1,137 |
| 3 years | +12.39% | +38.02% | £1,124 |
| 5 years | +5.25% | +42.60% | £1,053 |
| 10 years | −24.53% | +52.65% | £755 |
Over the last 6 months it has done better than 43% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. FTSE 100: price only. Calculate your investment
The chart in detail
Spire Healthcare Group: technical analysis
Spire Healthcare Group is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 37.9% below its all-time closing high (401.60 GBp, August 20, 2015).
- Trend
- Upward
- RSI (14 sessions)
- 68
- Between 30 and 70
- vs 200-session average
- +16.69%
Active signals
New 52-week high.
The price is moving in an unusually narrow range compared with the last year.
since September 30, 2026
Trading on November 20, 2026 was 4.5 times the 20-session average.
Support and resistance
Price areas where Spire Healthcare Group has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price249.50 GBp
- Support246.03 GBp−1.39%15 touches, last on November 6, 2026
- Support237.00 GBp−5.01%2 touches, last on August 6, 2026
- Support229.38 GBp−8.07%4 touches, last on August 24, 2026
Volatility and risk
Over the last year it has moved less than the FTSE 100.
- Beta (1 year) vs FTSE 100
- 0.56
- Volatility (60 sessions, annualised)
- 8.5%
- Largest fall in the last year
- −37.78%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Spire Healthcare Group: seasonality
Average monthly price change over 13 years
Over the last 13 years, the strongest month for Spire Healthcare Group has been May: +6.70% on average, positive in 9 years out of 12. The weakest has been March: −4.79% on average, positive in 6 years out of 12. November, the current month, has been positive in 7 years out of 12 (+1.02% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.56% | +3.42% | 7 of 12 |
| February | −2.18% | −1.83% | 3 of 12 |
| March | −4.79% | +0.53% | 6 of 12 |
| April | +4.97% | +6.89% | 9 of 12 |
| May | +6.70% | +2.36% | 9 of 12 |
| June | −1.80% | −3.71% | 4 of 12 |
| July | +0.79% | +0.01% | 6 of 12 |
| August | +0.10% | −0.46% | 6 of 13 |
| September | −0.71% | +3.49% | 8 of 13 |
| October | +2.51% | +0.70% | 7 of 13 |
| November | +1.02% | +4.31% | 7 of 12 |
| December | +1.33% | +1.01% | 7 of 12 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Spire Healthcare Group and its competitors
Its Hospitals Business segment owns and operates private hospitals and clinics across the United Kingdom, offering diagnostics, inpatient, day case and outpatient care in orthopaedics, cardiology, oncology, gynaecology and general surgery, alongside treatments such as hip and knee replacement, cataract removal, cosmetic surgery and weight loss procedures. Its hospitals also serve patients in areas such as neurology, neurosurgery, urology and vascular surgery. The Primary Care segment provides GP services, occupational health and mental and physical health services to outpatients.
- Headquarters
- London, United Kingdom
- Employees
- 17,800
- Founded
- 2007
- Chief executive
- David Sloman
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Spire Healthcare GroupSPI | $1.3B | 7.6% | — | +12.90% |
| TerveystaloTTALO | $830.61M | 8.9% | 13.0 | −27.00% |
| MedicoverMCOV.B | $3.82B | 7.4% | 38.3 | +19.86% |
| Fresenius Medical CareFME | $10.72B | 10.1% | 12.3 | −2.36% |
| FreseniusFRE | $31.8B | 9.9% | 18.4 | +27.91% |
| Mouwasat Medical Services4002 | $3.16B | 25.8% | 13.5 | −14.59% |
Same industry or related industries, similar size. Compare Spire Healthcare Group with its competitors · Full profile
